Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert P Schleimer

Showing results (1-10 of 215) with videos related to

Pageof 22
Sort By:
Proceedings of the American Thoracic Society|November 4, 2005
Innate immune responses and chronic obstructive pulmonary disease: "Terminator" or "Terminator 2"?Robert P Schleimer
Annual Review of Pathology|December 14, 2016
Immunopathogenesis of Chronic Rhinosinusitis and Nasal PolyposisRobert P Schleimer
Proceedings of the American Thoracic Society|August 23, 2005
Glucocorticoids suppress inflammation but spare innate immune responses in airway epitheliumRobert P Schleimer
Current Opinion in Immunology|October 12, 2007
Beyond inflammation: airway epithelial cells are at the interface of innate and adaptive immunityAtsushi Kato, Robert P Schleimer
The Journal of Allergy and Clinical Immunology|March 9, 2020
Formation of nasal polyps: The roles of innate type 2 inflammation and deposition of fibrinTetsuji Takabayashi, Robert P Schleimer
The Journal of Allergy and Clinical Immunology|February 18, 2003
Corticosteroid treatment in bronchial asthma: for better or for worse?Eckard Hamelmann, Robert P Schleimer
International Journal of Molecular Sciences|November 13, 2021
Epithelial-Cell-Derived Extracellular Vesicles in Pathophysiology of Epithelial Injury and Repair in Chronic Rhinosinusitis: Connecting Immunology in Research Lab to Biomarkers in ClinicsToru Takahashi, Robert P Schleimer
The Journal of Allergy and Clinical Immunology|June 7, 2017
Etiology of epithelial barrier dysfunction in patients with type 2 inflammatory diseasesRobert P Schleimer, Sergejs Berdnikovs
Tissue Barriers|July 1, 2017
The barrier hypothesis and Oncostatin M: Restoration of epithelial barrier function as a novel therapeutic strategy for the treatment of type 2 inflammatory diseaseKathryn L Pothoven, Robert P Schleimer
Current Molecular Medicine|August 12, 2008
Interleukin-4, interleukin-13, signal transducer and activator of transcription factor 6, and allergic asthmaDouglas A Kuperman, Robert P Schleimer
Pageof 22

Showing results (1-10 of 215) with videos related to

Sort By:
Pageof 22
Proceedings of the American Thoracic Society|November 4, 2005
Innate immune responses and chronic obstructive pulmonary disease: "Terminator" or "Terminator 2"?Robert P Schleimer
Annual Review of Pathology|December 14, 2016
Immunopathogenesis of Chronic Rhinosinusitis and Nasal PolyposisRobert P Schleimer
Proceedings of the American Thoracic Society|August 23, 2005
Glucocorticoids suppress inflammation but spare innate immune responses in airway epitheliumRobert P Schleimer
Current Opinion in Immunology|October 12, 2007
Beyond inflammation: airway epithelial cells are at the interface of innate and adaptive immunityAtsushi Kato, Robert P Schleimer
The Journal of Allergy and Clinical Immunology|March 9, 2020
Formation of nasal polyps: The roles of innate type 2 inflammation and deposition of fibrinTetsuji Takabayashi, Robert P Schleimer
The Journal of Allergy and Clinical Immunology|February 18, 2003
Corticosteroid treatment in bronchial asthma: for better or for worse?Eckard Hamelmann, Robert P Schleimer
International Journal of Molecular Sciences|November 13, 2021
Epithelial-Cell-Derived Extracellular Vesicles in Pathophysiology of Epithelial Injury and Repair in Chronic Rhinosinusitis: Connecting Immunology in Research Lab to Biomarkers in ClinicsToru Takahashi, Robert P Schleimer
The Journal of Allergy and Clinical Immunology|June 7, 2017
Etiology of epithelial barrier dysfunction in patients with type 2 inflammatory diseasesRobert P Schleimer, Sergejs Berdnikovs
Tissue Barriers|July 1, 2017
The barrier hypothesis and Oncostatin M: Restoration of epithelial barrier function as a novel therapeutic strategy for the treatment of type 2 inflammatory diseaseKathryn L Pothoven, Robert P Schleimer
Current Molecular Medicine|August 12, 2008
Interleukin-4, interleukin-13, signal transducer and activator of transcription factor 6, and allergic asthmaDouglas A Kuperman, Robert P Schleimer
Pageof 22